Brief: Deciphera Pharmaceuticals Announces Fourth Quarter And Full Year 2022 Financial Results
07/02/2023 12:07
Feb 7 (Reuters) - Deciphera Pharmaceuticals Inc
DCPH.O :
* DECIPHERA PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND
FULL YEAR
2022 FINANCIAL RESULTS
* QTRLY NET LOSS OF $0.60 PER SHARE
* QTRLY TOTAL REVENUE $36.3 MILLION
* Q4 EARNINGS PER SHARE VIEW $-0.56, REVENUE VIEW $35.7
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nBw5kjhQma
Further company coverage: DCPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions